Literature DB >> 8354898

Tuberculosis symposium: emerging problems and promise.

J J Ellner1, A R Hinman, S W Dooley, M A Fischl, K A Sepkowitz, M J Goldberger, T M Shinnick, M D Iseman, W R Jacobs.   

Abstract

Between 1985 and 1991, 39,000 cases of tuberculosis occurred in excess of those expected based on previous trends. Immigration from high-prevalence countries, coinfection with human immunodeficiency virus (HIV), and outbreaks in congregative facilities are most responsible for the increase. Coincident with the increase in tuberculosis, outbreaks of multidrug resistant (MDR) tuberculosis have occurred. Clinical and epidemiologic data support nosocomial transmission. MDR tuberculosis occurred late in the course of HIV infection and was refractory to treatment. Compounding the problems of rising incidence and increasing resistance was the sudden recognition of shortages of antituberculous drugs. The problems currently posed by tuberculosis require new approaches to diagnosis and rapid sensitivity testing as well as assuring an adequate supply of licensed drugs and development of new drugs. A number of steps have been taken by governmental agencies to assure that the challenge is met.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354898     DOI: 10.1093/infdis/168.3.537

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Knowledge and awareness of tuberculosis among pre-university students in Trinidad.

Authors:  F A Orrett; S M Shurland
Journal:  J Community Health       Date:  2001-12

2.  Detection of acid-fast bacilli in concentrated primary specimen smears stained with rhodamine-auramine at room temperature and at 37 degrees C.

Authors:  Y S McCarter; A Robinson
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

3.  Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.

Authors:  S L Moghazeh; X Pan; T Arain; C K Stover; J M Musser; B N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells.

Authors:  P Méndez-Samperio; E Garcia-Martinez; M Hernandez-Garay; M Solis-Cardona
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  False positive tuberculosis skin test results.

Authors:  J C Grabau; G T DiFerdinando; L F Novick
Journal:  Public Health Rep       Date:  1995 Nov-Dec       Impact factor: 2.792

6.  Multivariate Markovian modeling of tuberculosis: forecast for the United States.

Authors:  S M Debanne; R A Bielefeld; G M Cauthen; T M Daniel; D Y Rowland
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

7.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

Review 8.  Tuberculosis at the end of the twentieth century.

Authors:  K A Sepkowitz; J Raffalli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

9.  Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis.

Authors:  T J Hellyer; L E DesJardin; G L Hehman; M D Cave; K D Eisenach
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model.

Authors:  S P Klemens; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.